1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In-vitro Toxicity Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Static Well Plate System
1.2.3 Multi-compartmental Perfused Systems
1.3 Market by Application
1.3.1 Global In-vitro Toxicity Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Pharmaceutical and Biotechnology Companies
1.3.3 Academic and Research Institutions
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global In-vitro Toxicity Testing Market Perspective (2016-2027)
2.2 In-vitro Toxicity Testing Growth Trends by Regions
2.2.1 In-vitro Toxicity Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 In-vitro Toxicity Testing Historic Market Share by Regions (2016-2021)
2.2.3 In-vitro Toxicity Testing Forecasted Market Size by Regions (2022-2027)
2.3 In-vitro Toxicity Testing Industry Dynamic
2.3.1 In-vitro Toxicity Testing Market Trends
2.3.2 In-vitro Toxicity Testing Market Drivers
2.3.3 In-vitro Toxicity Testing Market Challenges
2.3.4 In-vitro Toxicity Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In-vitro Toxicity Testing Players by Revenue
3.1.1 Global Top In-vitro Toxicity Testing Players by Revenue (2016-2021)
3.1.2 Global In-vitro Toxicity Testing Revenue Market Share by Players (2016-2021)
3.2 Global In-vitro Toxicity Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by In-vitro Toxicity Testing Revenue
3.4 Global In-vitro Toxicity Testing Market Concentration Ratio
3.4.1 Global In-vitro Toxicity Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In-vitro Toxicity Testing Revenue in 2020
3.5 In-vitro Toxicity Testing Key Players Head office and Area Served
3.6 Key Players In-vitro Toxicity Testing Product Solution and Service
3.7 Date of Enter into In-vitro Toxicity Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 In-vitro Toxicity Testing Breakdown Data by Type
4.1 Global In-vitro Toxicity Testing Historic Market Size by Type (2016-2021)
4.2 Global In-vitro Toxicity Testing Forecasted Market Size by Type (2022-2027)
5 In-vitro Toxicity Testing Breakdown Data by Application
5.1 Global In-vitro Toxicity Testing Historic Market Size by Application (2016-2021)
5.2 Global In-vitro Toxicity Testing Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America In-vitro Toxicity Testing Market Size (2016-2027)
6.2 North America In-vitro Toxicity Testing Market Size by Type
6.2.1 North America In-vitro Toxicity Testing Market Size by Type (2016-2021)
6.2.2 North America In-vitro Toxicity Testing Market Size by Type (2022-2027)
6.2.3 North America In-vitro Toxicity Testing Market Size by Type (2016-2027)
6.3 North America In-vitro Toxicity Testing Market Size by Application
6.3.1 North America In-vitro Toxicity Testing Market Size by Application (2016-2021)
6.3.2 North America In-vitro Toxicity Testing Market Size by Application (2022-2027)
6.3.3 North America In-vitro Toxicity Testing Market Size by Application (2016-2027)
6.4 North America In-vitro Toxicity Testing Market Size by Country
6.4.1 North America In-vitro Toxicity Testing Market Size by Country (2016-2021)
6.4.2 North America In-vitro Toxicity Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe In-vitro Toxicity Testing Market Size (2016-2027)
7.2 Europe In-vitro Toxicity Testing Market Size by Type
7.2.1 Europe In-vitro Toxicity Testing Market Size by Type (2016-2021)
7.2.2 Europe In-vitro Toxicity Testing Market Size by Type (2022-2027)
7.2.3 Europe In-vitro Toxicity Testing Market Size by Type (2016-2027)
7.3 Europe In-vitro Toxicity Testing Market Size by Application
7.3.1 Europe In-vitro Toxicity Testing Market Size by Application (2016-2021)
7.3.2 Europe In-vitro Toxicity Testing Market Size by Application (2022-2027)
7.3.3 Europe In-vitro Toxicity Testing Market Size by Application (2016-2027)
7.4 Europe In-vitro Toxicity Testing Market Size by Country
7.4.1 Europe In-vitro Toxicity Testing Market Size by Country (2016-2021)
7.4.2 Europe In-vitro Toxicity Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific In-vitro Toxicity Testing Market Size (2016-2027)
8.2 Asia-Pacific In-vitro Toxicity Testing Market Size by Type
8.2.1 Asia-Pacific In-vitro Toxicity Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific In-vitro Toxicity Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific In-vitro Toxicity Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific In-vitro Toxicity Testing Market Size by Application
8.3.1 Asia-Pacific In-vitro Toxicity Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific In-vitro Toxicity Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific In-vitro Toxicity Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific In-vitro Toxicity Testing Market Size by Region
8.4.1 Asia-Pacific In-vitro Toxicity Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific In-vitro Toxicity Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America In-vitro Toxicity Testing Market Size (2016-2027)
9.2 Latin America In-vitro Toxicity Testing Market Size by Type
9.2.1 Latin America In-vitro Toxicity Testing Market Size by Type (2016-2021)
9.2.2 Latin America In-vitro Toxicity Testing Market Size by Type (2022-2027)
9.2.3 Latin America In-vitro Toxicity Testing Market Size by Type (2016-2027)
9.3 Latin America In-vitro Toxicity Testing Market Size by Application
9.3.1 Latin America In-vitro Toxicity Testing Market Size by Application (2016-2021)
9.3.2 Latin America In-vitro Toxicity Testing Market Size by Application (2022-2027)
9.3.3 Latin America In-vitro Toxicity Testing Market Size by Application (2016-2027)
9.4 Latin America In-vitro Toxicity Testing Market Size by Country
9.4.1 Latin America In-vitro Toxicity Testing Market Size by Country (2016-2021)
9.4.2 Latin America In-vitro Toxicity Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In-vitro Toxicity Testing Market Size (2016-2027)
10.2 Middle East & Africa In-vitro Toxicity Testing Market Size by Type
10.2.1 Middle East & Africa In-vitro Toxicity Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa In-vitro Toxicity Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa In-vitro Toxicity Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa In-vitro Toxicity Testing Market Size by Application
10.3.1 Middle East & Africa In-vitro Toxicity Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa In-vitro Toxicity Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa In-vitro Toxicity Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa In-vitro Toxicity Testing Market Size by Country
10.4.1 Middle East & Africa In-vitro Toxicity Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa In-vitro Toxicity Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories In-vitro Toxicity Testing Introduction
11.1.4 Abbott Laboratories Revenue in In-vitro Toxicity Testing Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 Agilent Technologies Inc.
11.2.1 Agilent Technologies Inc. Company Details
11.2.2 Agilent Technologies Inc. Business Overview
11.2.3 Agilent Technologies Inc. In-vitro Toxicity Testing Introduction
11.2.4 Agilent Technologies Inc. Revenue in In-vitro Toxicity Testing Business (2016-2021)
11.2.5 Agilent Technologies Inc. Recent Development
11.3 Bio-Rad Laboratories Inc.
11.3.1 Bio-Rad Laboratories Inc. Company Details
11.3.2 Bio-Rad Laboratories Inc. Business Overview
11.3.3 Bio-Rad Laboratories Inc. In-vitro Toxicity Testing Introduction
11.3.4 Bio-Rad Laboratories Inc. Revenue in In-vitro Toxicity Testing Business (2016-2021)
11.3.5 Bio-Rad Laboratories Inc. Recent Development
11.4 CELTHER POLSKA Sp z o.o.
11.4.1 CELTHER POLSKA Sp z o.o. Company Details
11.4.2 CELTHER POLSKA Sp z o.o. Business Overview
11.4.3 CELTHER POLSKA Sp z o.o. In-vitro Toxicity Testing Introduction
11.4.4 CELTHER POLSKA Sp z o.o. Revenue in In-vitro Toxicity Testing Business (2016-2021)
11.4.5 CELTHER POLSKA Sp z o.o. Recent Development
11.5 Charles River Laboratories International Inc.
11.5.1 Charles River Laboratories International Inc. Company Details
11.5.2 Charles River Laboratories International Inc. Business Overview
11.5.3 Charles River Laboratories International Inc. In-vitro Toxicity Testing Introduction
11.5.4 Charles River Laboratories International Inc. Revenue in In-vitro Toxicity Testing Business (2016-2021)
11.5.5 Charles River Laboratories International Inc. Recent Development
11.6 Eurofins GSC Lux Sarl
11.6.1 Eurofins GSC Lux Sarl Company Details
11.6.2 Eurofins GSC Lux Sarl Business Overview
11.6.3 Eurofins GSC Lux Sarl In-vitro Toxicity Testing Introduction
11.6.4 Eurofins GSC Lux Sarl Revenue in In-vitro Toxicity Testing Business (2016-2021)
11.6.5 Eurofins GSC Lux Sarl Recent Development
11.7 Evotec AG
11.7.1 Evotec AG Company Details
11.7.2 Evotec AG Business Overview
11.7.3 Evotec AG In-vitro Toxicity Testing Introduction
11.7.4 Evotec AG Revenue in In-vitro Toxicity Testing Business (2016-2021)
11.7.5 Evotec AG Recent Development
11.8 General Electric Co.
11.8.1 General Electric Co. Company Details
11.8.2 General Electric Co. Business Overview
11.8.3 General Electric Co. In-vitro Toxicity Testing Introduction
11.8.4 General Electric Co. Revenue in In-vitro Toxicity Testing Business (2016-2021)
11.8.5 General Electric Co. Recent Development
11.9 Merck KGaA
11.9.1 Merck KGaA Company Details
11.9.2 Merck KGaA Business Overview
11.9.3 Merck KGaA In-vitro Toxicity Testing Introduction
11.9.4 Merck KGaA Revenue in In-vitro Toxicity Testing Business (2016-2021)
11.9.5 Merck KGaA Recent Development
11.10 Thermo Fisher Scientific Inc.
11.10.1 Thermo Fisher Scientific Inc. Company Details
11.10.2 Thermo Fisher Scientific Inc. Business Overview
11.10.3 Thermo Fisher Scientific Inc. In-vitro Toxicity Testing Introduction
11.10.4 Thermo Fisher Scientific Inc. Revenue in In-vitro Toxicity Testing Business (2016-2021)
11.10.5 Thermo Fisher Scientific Inc. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
【免責事項】
https://www.globalresearch.jp/disclaimer